Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/06/09 → 30/05/11 |
Funding
- MSD (Merck Sharp & Dohme Australia) Pty Ltd: A$197,600.00
Characterisation of potential therapeutic effects of DPP-IV inhibition in models of vascular endothelial cell dysfunction and atherosclerosis.
- Simpson, Richard (Primary Chief Investigator (PCI))
- Dear, Anthony (Chief Investigator (CI))
Project: Research